NYSE: CMBTCmbtech Nv Stock
$11.47-0.05 (-0.43%)
Updated Jan 16, 2026
CMBT Price
$11.47
Fair Value Price
N/A
Market Cap
$3.33B
52 Week Low
$7.65
52 Week High
$11.85
P/E
13.82x
P/B
1.31x
P/S
1.44x
PEG
0.28x
Dividend Yield
N/A
Revenue
$1.55B
Earnings
$164.77M
Gross Margin
59.3%
Operating Margin
34.66%
Profit Margin
10.6%
Debt to Equity
2.28
Operating Cash Flow
$326M
Beta
0.59
Next Earnings
Feb 26, 2026
Ex-Dividend
N/A
Next Dividend
N/A
CMBT Overview
Euronav NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. Euronav was founded in 1995 and is headquartered in Antwerp, Belgium.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CMBT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Oil & Gas Midstream
Industry Rating
D
CMBT
Ranked#35 of 43
Ranked#35 of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $33.24 | B | |
| $28.49 | B | |
| $13.26 | B |
Be the first to know about important CMBT news, forecast changes, insider trades & much more!
CMBT News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CMBT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CMBT ($11.47) is trading below its intrinsic value of $19.77, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CMBT is good value based on its earnings relative to its share price (13.82x), compared to the US market average (46.6x)
P/E vs Market Valuation
CMBT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CMBT due diligence checks available for Premium users.
Valuation
CMBT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.82x
Industry
19.49x
Market
46.6x
CMBT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CMBT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CMBT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.31x
Industry
2.86x
CMBT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CMBT price to earnings growth (PEG)
For valuing profitable companies with growth potential
CMBT is good value based... subscribe to Premium to read more.
PEG Value Valuation
CMBT's financial health
Profit margin
Revenue
$501.6M
Net Income
$19.9M
Profit Margin
4%
CMBT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CMBT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.4B
Liabilities
$5.8B
Debt to equity
2.28
CMBT's short-term liabilities ($822.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CMBT's long-term liabilities ($4.99B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CMBT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CMBT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$138.5M
Investing
-$164.2M
Financing
-$50.0M
CMBT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CMBT vs Oil & Gas Midstream Stocks
Cmbtech Nv Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.